Trial Profile
To evaluate the efficacy and safety of Secukinumab in patients with moderate to severe psoriasis : a real world,multicenter,retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2017
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2017 New trial record